inveox Competitors and Similar CompaniesClear all
A28 Therapeutics's competitors and similar companies include Immunovia and bioAffinity Technologies.
 A28 Therapeutics A28 Therapeutics is a biopharmaceutical company focused on the development of a targeted oncolytic peptide platform for the treatment of multiple cancer types. |  Immunovia Immunovia engages in the development of a technology platform based on antibody microarray analysis. |  bioAffinity Technologies bioAffinity Technologies is a company focusing on the diagnosis of early-stage cancer, diseases of the lung, and targeted cancer treatment. | |
Founding Date | Founding Date 2021 | Founding Date 2007 | Founding Date 2014 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations La Jolla, US HQ | Locations Lund, SE HQ Lund, SE Marlborough, US | Locations San Antonio, US HQ San Antonio, US |
Employees | Employees 7 | Employees 9 | Employees 11 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 10.2 m | Valuation ($) 21.1 m |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) kr685k (FY, 2025) | Revenue (est.) $6.2m (FY, 2025) |
Net income | Net income N/A | Net income (kr145.9m) (FY, 2025) | Net income ($14.9m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 5.2m | Total funding raised $ 4.2m |
For sources of this data, please see the company profile
View Company Profiles
Immunovia
HQ
Lund, SE
Employees
9
Immunovia engages in the development of a technology platform based on antibody microarray analysis.
View companybioAffinity Technologies
HQ
San Antonio, US
Employees
11
bioAffinity Technologies is a company focusing on the diagnosis of early-stage cancer, diseases of the lung, and targeted cancer treatment.
View company